Table 3: Clinical characteristics of neonates born to mothers with COVID-19 admitted to NICU N = 60 neonates born to 53 mothers.
|
Neonates exposed but uninfected N = 58 |
Neonates COVID-19 N = 2 |
Male |
31 (53%) |
0 |
Female |
27 (47%) |
2 (100%) |
Term >= 37 weeks |
25 (43%) |
1 (50%) |
Late Preterm 34- 36 weeks |
27 (47%) |
1 (50%) |
Preterm < 34 weeks |
6 (10%) |
0 |
Symptoms and Complications |
|
|
Fever |
4 (7%) |
0 |
Respiratory Distress Syndrome |
16 (28%) |
0 |
Transient Tachypnea of the Newborn |
21 (36%) |
0 |
Pneumonia* |
1 (2%) |
0 |
Hypoglycemia |
8 (14%) |
0 |
Hyperbilirubinemia |
10 (17%) |
2 (100%) |
Treatment |
|
|
Mechanical Ventilation |
1 (2%) |
0 |
NCPAP |
34(59%) |
0 |
Antibiotics |
34 (59%) |
1 (50%) |
Surfactant |
1 (2%) |
0 |
Outcome of Neonate |
|
|
Discharged Home |
58 (100%) |
2 (100%) |
Died |
0 |
0 |
Maternal Symptoms at time of Delivery. N = 53 mothers |
|
|
Yes |
7 (14%) |
2 (100%) |
No |
44 (86%) |
0 |
Maternal Symptoms. N = 7** |
|
|
Fever |
7 |
2 |
Cough |
6 |
2 |
Myalgia |
1 |
0 |
Anosmia or Ageusia |
2 |
0 |
Respiratory Distress/lower respiratory symptoms |
1 |
0 |
Maternal Outcome |
|
|
ICU Admission |
1 (2%) |
0 |
Death |
1 (2%) |
0 |
*one neonate had nonspecific densities on both lungs but also had congenital heart disease. This was not included in the table; **some mothers had more than one symptom.